Literature DB >> 17000386

Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis.

Steven A Earle1, Eduardo A Perez, Juan C Gutierrez, Danny Sleeman, Alan S Livingstone, Dido Franceschi, Joe U Levi, Craig Robbins, Leonidas G Koniaris.   

Abstract

OBJECTIVE: This study was done to determine the benefit of undergoing liver resection for noncolorectal metastasis.
METHODS: A single-institution retrospective review of all patients (n = 95) who underwent hepatic resection for a noncolorectal liver metastasis from 1990 to 2005 was performed. Primary outcomes measure was months of patient survival after liver resection.
RESULTS: Median patient age was 58 years (range 19 to 83 years). There were 37 men (38.9%) and 58 women (61.1%). The 30-day postoperative mortality rate was 2.1%, and postoperative complications developed in 15.8% of patients. Mean hospital stay was 7 days (range 4 to 25 days). Median time of survival from date of liver resection was 36 months, and 5-year survival rate was 34.9%. Primary tumor sites were identified as foregut or gastrointestinal in 16.8% and nongastrointestinal in 83.2%. Patients with a nonforegut primary tumor had a median survival time twice as long as those with foregut primaries (49 months versus 20 months, p < 0.001). Multiple liver metastases were an independent prognostic factor for worse outcomes with a hazard ratio of 3.3 (p = 0.007). No treatment-dependent variables (initial treatment modality, extent of liver resection, margins, complications) were found on multivariable analysis to be important prognostic factors.
CONCLUSIONS: In select patients with any of a variety of malignancies metastatic to the liver, prolonged survival can result from liver resection, especially in those with a single, resectable tumor from a nongastrointestinal primary site.

Entities:  

Mesh:

Year:  2006        PMID: 17000386     DOI: 10.1016/j.jamcollsurg.2006.06.031

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  17 in total

1.  Conformational technique for non-anatomic resection of liver lesions.

Authors:  Peter J Dipasco; Subhasis Misra; Leonidas G Koniaris
Journal:  J Gastrointest Surg       Date:  2012-07-11       Impact factor: 3.452

2.  Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome.

Authors:  Andreas Andreou; Antoine Brouquet; Kishore G S Bharathy; Nancy D Perrier; Eddie K Abdalla; Steven A Curley; Matthias Glanemann; Daniel Seehofer; Peter Neuhaus; Jean-Nicolas Vauthey; Thomas A Aloia
Journal:  Surgery       Date:  2012-02-04       Impact factor: 3.982

3.  Survival Benefits of Surgical Resection in Patients with Recurrent Biliary Tract Carcinoma.

Authors:  Hiroaki Motoyama; Akira Kobayashi; Takahide Yokoyama; Akira Shimizu; Noriyuki Kitagawa; Tsuyoshi Notake; Kentaro Fukushima; Hitoshi Masuo; Takahiro Yoshizawa; Shin-Ichi Miyagawa
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

4.  Surgery for liver metastases originating from sarcoma-case series.

Authors:  Maximilian Zacherl; Gerwin A Bernhardt; Johannes Zacherl; Gerald Gruber; Peter Kornprat; Heinz Bacher; Hans-Jörg Mischinger; Reinhard Windhager; Raimund Jakesz; Thomas Grünberger
Journal:  Langenbecks Arch Surg       Date:  2011-07-08       Impact factor: 3.445

5.  Liver Resection for Non-colorectal Non-neuroendocrine Metastases: Where Do We Stand Today Compared to Colorectal Cancer?

Authors:  Tobias S Schiergens; Juliane Lüning; Bernhard W Renz; Michael Thomas; Sebastian Pratschke; Hao Feng; Serene M L Lee; Jutta Engel; Markus Rentsch; Markus Guba; Jens Werner; Wolfgang E Thasler
Journal:  J Gastrointest Surg       Date:  2016-02-26       Impact factor: 3.452

Review 6.  The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review.

Authors:  Timothy L Fitzgerald; Jason Brinkley; Shannon Banks; Nasreen Vohra; Zachary P Englert; Emmanuel E Zervos
Journal:  Langenbecks Arch Surg       Date:  2014-08-23       Impact factor: 3.445

7.  Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?

Authors:  Leonidas G Koniaris; David M Levi; Felipe E Pedroso; Dido Franceschi; Andreas G Tzakis; Juan A Santamaria-Barria; Jennifer Tang; Marissa Anderson; Subhasis Misra; Naveenraj L Solomon; Xiaoling Jin; Peter J DiPasco; Margaret M Byrne; Teresa A Zimmers
Journal:  Ann Surg       Date:  2011-09       Impact factor: 12.969

8.  Non-colorectal, non-neuroendocrine, and non-sarcoma metastases of the liver: resection as a promising tool in the palliative management.

Authors:  Moritz Schmelzle; Claus F Eisenberger; Jan Schulte am Esch; Hanno Matthaei; Markus Krausch; Wolfram T Knoefel
Journal:  Langenbecks Arch Surg       Date:  2009-12-09       Impact factor: 3.445

9.  Hepatic resection for non-colorectal, non-neuroendocrine, non-sarcoma metastasis: a single-centre experience.

Authors:  Ravi Marudanayagam; Bynvant Sandhu; M Thamara P R Perera; Phillipe Taniere; Chris Coldham; Simon Bramhall; David Mayer; John Buckels; Darius Mirza
Journal:  HPB (Oxford)       Date:  2011-03-02       Impact factor: 3.647

10.  Liver resection for non-colorectal, non-neuroendocrine metastases: analysis of a multicenter study from Argentina.

Authors:  J Lendoire; M Moro; O Andriani; J Grondona; O Gil; G Raffin; J Silva; R Bracco; G Podestá; C Valenzuela; O Imventarza; J Pekolj; E De Santibañes
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.